Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sangiorgio

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Minerva Cardioangiologica|December 6, 2001
Outcome of percutaneous coronary angioplasty (PTCA) performed in a low-volume institution by low-volume operators, evaluated by means of the one-month major adverse cardiac event rateA Rubboli, R Brancaleoni, D E Euler, et al.
American Journal of Nephrology|January 1, 1986
Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patientsA Salvetti, G Leonetti, G P Bernini, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Minerva Cardioangiologica|December 6, 2001
Outcome of percutaneous coronary angioplasty (PTCA) performed in a low-volume institution by low-volume operators, evaluated by means of the one-month major adverse cardiac event rateA Rubboli, R Brancaleoni, D E Euler, et al.
American Journal of Nephrology|January 1, 1986
Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patientsA Salvetti, G Leonetti, G P Bernini, et al.
Pageof 4